Back
Raymond James Financial Vs. Bright Minds Biosciences Industry Stock Comparison
Buy
54
RJF
Raymond James Financial
Last Price:
$151.71
Seasonality Move:
1.16%
Sell
30
DRUG
Bright Minds Biosciences
Last Price:
$35.58
Seasonality Move:
-44.9%
Buy
54
Raymond James Financial (RJF)
is a Buy
Is Raymond James Financial a Buy, Sell or Hold?
-
The current Raymond James Financial [RJF] share price is $151.54. The Score for RJF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
-
RJF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Bright Minds Biosciences (DRUG)
is a Sell
Is Bright Minds Biosciences a Buy, Sell or Hold?
-
The current Bright Minds Biosciences [DRUG] share price is $35.99. The Score for DRUG is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
-
DRUG is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
RJF Stock Price Chart
What is Raymond James Financial's stock price today?
-
The Raymond James Financial share price today is $151.54Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RJF is experiencing selling pressure, which indicates risk of future bearish movement.
DRUG Stock Price Chart
What is Bright Minds Biosciences's stock price today?
-
The Bright Minds Biosciences share price today is $35.99Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DRUG is experiencing selling pressure, which indicates risk of future bearish movement.
RJF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.97 | Sell |
Relative Strength Index (14 RSI): | 29.76 | Sell |
Chaikin Money Flow: | -963976 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (159.97 - 170.77) | Sell |
Bollinger Bands (100): | (140.84 - 168.42) | Sell |
DRUG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.49 | Buy |
Relative Strength Index (14 RSI): | 43.58 | Sell |
Chaikin Money Flow: | -57932 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.31 - 42.33) | Sell |
Bollinger Bands (100): | (21.62 - 49.12) | Buy |
RJF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 158.92 | Sell |
20-day SMA: | 164.53 | Sell |
50-day SMA: | 161.45 | Sell |
200-day SMA: | 136.71 | Buy |
8-day EMA: | 158.34 | Sell |
20-day EMA: | 161.64 | Sell |
50-day EMA: | 160.69 | Sell |
200-day EMA: | 142.25 | Buy |
DRUG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.66 | Sell |
20-day SMA: | 37.92 | Sell |
50-day SMA: | 38 | Sell |
200-day SMA: | 18.24 | Buy |
8-day EMA: | 38.81 | Sell |
20-day EMA: | 38.81 | Sell |
50-day EMA: | 37.51 | Sell |
200-day EMA: | 23.7 | Buy |
Raymond James Financial Earnings Growth & RJF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.19 per share, a decrease next quarter of $0.05 per share, an increase this year of $1.46 per share, and an increase next year of $0.95 per share.
Bright Minds Biosciences Earnings Growth & DRUG Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.11 per share, a decrease this year of $0.77 per share, and a decrease next year of $1.55 per share.
Raymond James Financial Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Bright Minds Biosciences Technical Analysis
Feb 7 | Feb 10 | Feb 11 | Feb 12 | Feb 13 | Feb 14 | Feb 18 | Feb 19 | Feb 20 | Feb 21 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | ||||||||||
07 | 10 | 11 | 12 | 13 | 14 | 18 | 19 | 20 | 21 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |